Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial

DOI: 10.1007/s13311-017-0572-5

Keywords: Neurotoxicity, Neuropathic pain, Adverse effects, Chemotherapy, Colorectal cancer, MR309/E-52862

Full-Text   Cite this paper   Add to My Lib

Abstract:

The online version of this article (10.1007/s13311-017-0572-5) contains supplementary material, which is available to authorized users

Full-Text